About

Medix Biotechnologies Inc., founded in December 2023 in Stanford, CA, develops AI‑enabled molecular diagnostics that bring laboratory‑grade testing and analysis into home and point‑of‑care settings. 

Medix is creating a highly multiplexed molecular self‑test that uses proprietary algorithms to detect multiple targets in a single assay, with results interpreted on a smartphone through an intuitive user experience. This approach addresses slow, fragmented, and often inaccurate diagnostic pathways by enabling comprehensive on‑site testing and reducing the need for multiple doctor and laboratory visits. 

Medix’s core competencies span assay design, complex software development, artificial intelligence, and cybersecurity. The company is led by a multidisciplinary team, headed by CEO and founder Ashok Babbar, a Silicon Valley veteran with more than 30 years of experience in building and exiting startups.